Tue, Sep 2, 2014, 12:33 AM EDT - U.S. Markets open in 8 hrs 57 mins


% | $
Quotes you view appear here for quick access.

Pharmacyclics Inc. Message Board

  • jgmtruth jgmtruth May 3, 2013 12:09 PM Flag

    Drug Manufacturers and the FDA Collaborate More Closely for Faster Drug Approval: An Exclusive Interview with an Expert Equity Analyst Reveals Some Top Stock Picks in This Vital Industry

    67 WALL STREET, New York - May 3, 2013 - The Wall Street Transcript has just published its Biotechnology and Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs and Equity Analysts. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.
    Topics covered: Health Care - Biotechnology and Pharmaceuticals - Executive Officer Interviews - Biotechnology and Pharmaceutical Investing - Orphan Drug and Biologics Manufacturing - Biotechnology and Pharmaceutical Companies Valuation
    Companies include: Medicines Co. (MDCO), Cubist Pharmaceuticals Inc. (CBST), Regeneron Pharmaceuticals Inc. (REGN), Seattle Genetics Inc. (SGEN), Immunogen Inc. (IMGN), Merck & Co. Inc. (MRK), Pharmacyclics Inc. (PCYC), Johnson & Johnson (JNJ), Gilead Sciences Inc. (GILD), Infinity Pharmaceuticals, Inc. (INFI), Celgene Corporation (CELG), Amgen Inc. (AMGN), Biogen Idec Inc. (BIIB) and many more.
    Sorry can't full article.

    Sentiment: Strong Buy

124.39+0.44(+0.35%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT